Cognition Therapeutics Inc (CGTX)
0.4612
-0.05
(-9.85%)
USD |
NASDAQ |
Nov 15, 16:00
0.4613
0.00 (0.00%)
After-Hours: 20:00
Cognition Therapeutics Total Assets (Quarterly): 34.37M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 34.37M |
March 31, 2024 | 38.85M |
December 31, 2023 | 35.16M |
September 30, 2023 | 38.77M |
June 30, 2023 | 43.96M |
March 31, 2023 | 45.66M |
December 31, 2022 | 50.42M |
September 30, 2022 | 53.56M |
Date | Value |
---|---|
June 30, 2022 | 52.81M |
March 31, 2022 | 58.70M |
December 31, 2021 | 59.14M |
September 30, 2021 | 13.39M |
June 30, 2021 | 17.29M |
March 31, 2021 | 16.51M |
December 31, 2020 | 7.119M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
7.119M
Minimum
Dec 2020
59.14M
Maximum
Dec 2021
37.71M
Average
38.85M
Median
Mar 2024
Total Assets (Quarterly) Benchmarks
NeuroBo Pharmaceuticals Inc | 22.15M |
Dermata Therapeutics Inc | 5.237M |
ZyVersa Therapeutics Inc | 19.47M |
NovaBay Pharmaceuticals Inc | 3.877M |
Palatin Technologies Inc | 10.74M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 11.36M |
Shareholders Equity (Quarterly) | 23.01M |